This research investigates whether activation of the sympathetic nervous system can enhance tissue regeneration. Using engineered neural switches in mice, the study demonstrated improved healing after ear injury, including growth of nerves, blood vessels, and cartilage. The findings suggest that nervous system regulation may play an important role in future regenerative medicine therapies.

This research explores asthma by recreating lung airways using 3D bioprinting. By simulating low-oxygen conditions and imaging structural changes, it investigates how exaggerated immune responses narrow airways. These models enable detailed study of disease mechanisms and offer a platform to develop treatments, ultimately advancing efforts toward preventing or curing asthma.

Despite major advances in medicine, wound care has changed little in a century. This research explores how natural electrical signals in injured skin guide healing. By developing devices that mimic these signals, scientists aim to accelerate recovery and improve treatment for chronic wounds through bioelectric control of cellular behaviour.

Acute respiratory distress syndrome (ARDS) causes severe breathing failure and kills tens of thousands annually, yet has no effective treatment. This research studies how ARDS disrupts lung surfactant, a critical stabilizing substance in the lungs. By identifying immune-related factors that damage surfactant, the work aims to develop the first targeted therapeutic cure.

This talk presents a new noninvasive MRI method to visualize the brain’s immune response. By imaging inflammation without injections or contrast agents, the research offers new insights into Alzheimer’s disease, ALS, and traumatic brain injury, helping researchers better understand how brain inflammation contributes to neurological disorders.

This research explores how mast cells—immune cells responsible for allergy symptoms—can be repurposed to strengthen vaccines. By targeting mast cells with nasal vaccines, stronger and longer-lasting immune responses may be generated, particularly benefiting high-risk populations and improving protection against infectious diseases.

Tuberculosis remains deadly despite relying on decades-old antibiotics. This research uses computational methods to identify immune response similarities between TB and other diseases, enabling drug repurposing. By borrowing already approved treatments, this approach aims to restore immune balance, combat drug resistance, and accelerate the development of new TB therapies.